Feedback / Questions
PAS-004 - Pasithea
https://www.globenewswire.com/news-release/2025/07/31/3124857/0/en/Pasithea-Therapeutics-Completes-Enrollment-and-Initial-Dosing-of-First-Cohort-from-its-Phase-1-1b-Clinical-Trial-of-PAS-004-in-Adult-NF1-Patients.html
Jul 31, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next